sun pharma semaglutide receives DCGI approval for Noveltreat, positioning itself strongly in India's fast-growing GLP-1 weight-management and diabetes therapy market ahead of patent expiry in 2026. #SunPharma #PharmaceuticalIndustry #GLP1 #Semaglutide Sun Pharma gets DCGI approval
Pay in 4 interest-free payments of $5.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24















![kentucky glp-1 bowel obstruction lawsuit Ozempic GLP-1 Lawsuit [2026]: Gastroparesis (Stomach Paralysis), Ileus & NAION Vision Loss Injury Cases](https://i0.wp.com/injurylawsuitconnect.com/wp-content/uploads/2025/08/Ozempic-Mounjaro-and-Wegovy-Lawsuit-Cases-and-Settlement-Claims-Who-May-Qualify-For-An-Ozempic-GLP1-Lawsuit-Case-or-Settlement-Claim.jpg?resize=819%2C1024&ssl=1)







